ResearcherAffiliated Hospital of Nantong UniversityNo recent work listed

Xiaoqing Xu

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0001-8294-6307; OpenAlex author ID A5101922270.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 1, last author 0)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper

Papers 1

Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT-3/TrkC signaling pathway. First author DOI 10.1002/jcla.24719 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Fuhai Ji · 1 shared paper, 2022
- Paper Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT-3/TrkC … DOI 10.1002/jcla.24719 ↗
Ke Peng · 1 shared paper, 2022
- Paper Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT-3/TrkC … DOI 10.1002/jcla.24719 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.